The Measure It! trial, led by Professor Nicole Freene and Dr. Rebecca Cesnik in Canberra, is a groundbreaking initiative that aims to revolutionize cancer care by promoting physical activity among chemotherapy patients. This innovative approach recognizes the importance of even small, incremental movements in managing side effects, speeding up recovery, and enhancing overall quality of life during cancer treatment. The trial's unique aspect lies in its focus on brief, frequent gentle pushes from healthcare providers, which can be seamlessly integrated into standard patient check-ins, taking less than five minutes. This strategy addresses a critical barrier to physical activity in cancer care: the lack of time and knowledge among busy healthcare professionals. By doing so, it empowers them to provide valuable guidance on physical activity, which is crucial for cancer patients' long-term health outcomes and quality of life. Research has shown that frequent measurements of physical activity by healthcare providers significantly increase patients' moderate to vigorous physical activity levels. In the ACT, only 12% of chemotherapy patients meet the recommended physical activity levels, despite a strong desire for guidance. However, the study highlights that simple activities like walking around the kitchen can contribute to this goal. The benefits of physical activity during cancer treatment are well-documented, including improved survival rates, reduced recurrence, and better treatment adherence. Moreover, it can significantly enhance patients' quality of life. The Measure It! trial is supported by the Cancer Council ACT, which has provided a $100,000 research grant to further local cancer research in Canberra. This funding is crucial for translating the research into practical applications for both healthcare professionals and cancer patients. The initiative's success is a testament to the power of local support, as exemplified by Daffodil Day, which has been running for 40 years. Daffodil Day, a significant fundraising event for cancer research, has seen the five-year cancer survival rate rise from 46% in 1986 to 72% today. Cancer Council ACT CEO Verity Hawkins emphasizes the direct impact of community generosity on cancer patients in the ACT. She encourages Canberrans to participate in Daffodil Day activities, such as wearing yellow, buying daffodils, hosting fundraisers, or donating, to support life-changing cancer research. This year, Daffodil Day marks its 40th anniversary, serving as a poignant reminder of the progress made in cancer treatment and the ongoing need for investment in vital research. The trial's success and the community's support highlight the potential for small, incremental changes to have a significant impact on cancer care, ultimately improving the lives of patients and their families.
